| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0249c8c96ed09a989cb0d43c51a3060d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07006 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07006 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34 |
| filingDate |
2021-12-21^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_647952b9e14b450880726d96e1ddc26e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5038977c009df867b2b0a72682354baf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dd98da0a37ab31c6522ca2b53f659e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4c04a31d25566e35768cf1f638ccc86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f670b99318450e0c642a9c2918a5b970
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee9682e1ce9f52bca72ec8a63dba7635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa5e30d9911ad97fb3158ba4882172d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c5eed050ef4db4da154155e8a15dac0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35ebfcdbb90ac839e1b405684ff6492b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1c14b2042e7e3ff1b2f45e062cd823e |
| publicationDate |
2022-06-16^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022186197-A1 |
| titleOfInvention |
T7 rna polymerase variants |
| abstract |
The present invention provides engineered RNA polymerase variants and compositions comprising these variants. The present invention further provides engineered T7 RNA polymerase variants and compositions comprising these variants. These variants have been evolved for selective incorporation of the m7G(5′)ppp(5′)m7G cap analog over GTP at the initiation of in vitro transcription. The present invention also provides methods for selective capping of RNA transcripts. |
| priorityDate |
2017-06-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |